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Background: The general prognosis of critically ill patients with cirrhosis is poor. We investigated the
inﬂuence of age (< 65 years, 65e74 years, and  75 years) on the short- and medium-term outcomes of
cirrhotic patients in the intensive-care-unit (ICU) setting.
Methods: This retrospective cohort study included 226 consecutive patients with liver cirrhosis who
were admitted to the ICU. Clinical outcomes, including ICU mortality, in-hospital mortality, ventilator-
free days, ICU days, ICU-free days, hospital days, and hospital-free days, were compared between the
different age groups.
Results: The overall ICU mortality in patients aged < 65 years, 65e74 years, and  75 years was 29.4%,
20.0%, and 30.3%, respectively. For patients with compensated cirrhosis, age showed no signiﬁcant cor-
relation with mortality or clinical outcomes. For patients with decompensated cirrhosis, age  75 years
was signiﬁcantly correlated with in-hospital mortality, 6-month mortality, hospital days, and hospital-
free days. After adjusting for sex, coronary artery disease, etiology of ICU admission, Acute Physiology
and Chronic Health Evaluation II score, Model for End-Stage Liver Disease score, and mechanical
ventilation, age  75 years remained signiﬁcant for in-hospital mortality (hazard ratio 2.61, 95% conﬁ-
dence interval 1.27e5.39, p ¼ 0.009) and 6-month mortality (hazard ratio 2.34, conﬁdence interval 1.16
e4.70, p ¼ 0.017).
Conclusion: During ICU stays, old age does not have adverse effects on ICUmortality, ventilator-free days,
ICU days, or ICU-free days in cirrhotic patients (either compensated or decompensated cirrhosis). After
ICU discharge, age  75 years is an independent prognostic factor for in-hospital mortality and 6-month
mortality in patients with decompensated cirrhosis.
Copyright © 2015, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
It has been suggested that intensive-care-unit (ICU) mortality
rates are higher in the elderly than in younger patients1; however,
several studies have also shown that it is not age per se, but other
factors that predict mortality, including diagnosis, comorbidity, and
premorbid cognitive and functional status2e4. Therefore, age alone
should not be a criterion for admission and use of ICU resources5.re that they have no conﬂicts
partment of Nephrology,
2, Zhongshan North Road,
hen).
tric Emergency & Critical Care MeMeanwhile, the incidence of liver cirrhosis is increasing expo-
nentially6. Regardless of the reason for admission to an ICU, the
presence of cirrhosis is independently associated with worse
prognosis of critically ill patients7. Das et al8 have shown that the
occurrence of three nonhematologic organ-system failures after 3
days in patients with cirrhosis was associated with a mortality rate
of almost 90%, and a 3-day trial of unrestrictive intensive care has
been proposed for cirrhotic patients. Therefore, predicting the
outcomes of critically ill patients with cirrhosis is important for
medical decision-making and for providing prognostic advice to
patients.
Studies have shown that, in elderly critically ill patients, the
severity of acute illness is an even stronger predictor of mortality
than age9,10. It has been suggested that the prognosis of cirrhotic
patients during ICU stays is not related to the severity of liverdicine. Published by Elsevier Taiwan LLC. All rights reserved.
C.-Y. Chen et al.234cirrhosis, but to the frequency of organ-system failure11. However,
these results were not veriﬁed in an elderly age group. Therefore,
we aimed to investigate the inﬂuence of age (< 65 years, 65e74
years, or  75 years) on short- and medium-term outcomes of
cirrhotic patients in the ICU setting.2. Materials and methods
2.1. Patients
The present retrospective study included consecutive adult pa-
tients with cirrhosis admitted to the medical ICU between August
2010 and April 2012. The study was performed according to the
principles of the Declaration of Helsinki, and approved by the Ethics
Committee of the Mackay Memorial Hospital, Taipei, Taiwan
(Institutional Review Board number 12MMHIS017).
Of the 9000 ICU patient records, we reviewed those of 299
cirrhotic patients. The exclusion criteria were end-stage renal dis-
ease with renal replacement (10 cases), admission for surgical in-
dications (25 cases), repeated ICU admissions during the study
period (33 cases), and loss to follow-up during the study period (5
cases). A total of 226 patients met the inclusion criteria for entry
into the study, and none of the study participants underwent liver
transplantation.2.2. Methods
The baseline characteristics of the participants included in the
analysis were age, sex, etiology of liver disease, reasons for ICU
admission, comorbidities, and Acute Physiology and Chronic Health
Evaluation II (APACHE II) score. Laboratory data on liver function,
Model for End-Stage Liver Disease score, ChildePugh score, renal
function, and electrolyte levels were also obtained upon admission
to the ICU. The clinical mortality (ICU mortality, in-hospital mor-
tality, and 6-month mortality) and outcomes [ventilator-free days
(VFDs), ICU days, ICU-free days, hospital days, and hospital-free
days] of patients aged < 65 years, 65e74 years, and  75 years
were compared.
The patients were classiﬁed into compensated and decom-
pensated cirrhosis groups. Compensated cirrhosiswas deﬁned as the
absence of variceal bleeding, clinical hepatic encephalopathy, se-
vere ascites, and hepatorenal syndrome on admission to the ICU.
VFDs were calculated as (28  x), where x was the number of
days spent receiving mechanical ventilation. For example, VFD ¼ 0
indicates patients who required mechanical ventilation for  28
days, or those who died before reaching 28 days on mechanical
ventilation in the ICU. ICU-free days were calculated as (30  x),
where xwas the number of days spent in the ICU. ICU-free days¼ 0
indicated patients who died before 30 days, or stayed in the ICU for
 30 days. Hospital-free days were calculated as 60  x, where x
was the number of days spent in the hospital. Hospital-free
days ¼ 0 indicated patients who spent > 60 days in the hospital,
or expired within 60 days during hospitalization.2.3. Statistical analysis
Continuous variables were expressed as mean ± standard error
of the mean unless otherwise stated. Analysis of variance (ANOVA)
and Chi-square tests were used to assess differences in clinical
outcomes in patients who were classiﬁed by age group. Cox
proportional-hazard regression analysis and linear-regression
analysis were used to investigate the association betweenparameters and clinical outcomes. All statistical analyses were
performed using SPSS software (version 17.0; SPSS Inc., Chicago, IL,
USA).3. Results
The baseline demographic, clinical, and laboratory characteris-
tics of the 226 enrolled patients are shown in Table 1. It should be
noted that most cases of cirrhosis in patients aged < 65 years were
related to alcohol consumption (68%), and most of these patients
were men. These patients had more severe liver disease at ICU
admission, represented by the high ChildePugh score, total bili-
rubin, and international normalized ratio. Male sex is a risk factor
for alcohol dependence and abuse in Taiwanese society. By contrast,
most cases of cirrhosis in patients aged 65e74 years and  75 years
were related to viral hepatitis.
ICU complications and clinical outcomes are listed in Table 2. A
signiﬁcantly higher proportion of cirrhosis-related complications
(hepatic encephalopathy and gastrointestinal bleeding) was noted
in patients aged < 65 years. For clinical outcomes, signiﬁcant dif-
ferences between age groups were noted in in-hospital mortality,
6-month mortality, and hospital-free days.
Portal hypertension is associated with some of the most severe
complications of cirrhosis, including ascites and bleeding from
gastroesophageal varices12. As portal pressure rises above
12 mmHg, the risk for gastroesophageal variceal hemorrhage in-
creases dramatically13. Acute variceal bleeding in cirrhotic patients
can be a dramatic event with severe gastrointestinal hemorrhage
manifesting as hematemesis with or without melena, and
commonly accompanied by hemodynamic instability, shock, and
fall in hemoglobin14. Even with the current best medical care,
mortality from variceal bleeding is still approximately 20%15. We
analyzed the gastrointestinal-bleeding group into variceal bleeding
and nonvariceal bleeding (Tables 1 and 2). We deﬁned variceal
bleeding according to the esophagogastroduodenoscopy result.
Active esophageal or gastric variceal bleeding was deﬁned as
bleeding from an esophageal or gastric varix at the time of
endoscopy, or the presence of large esophageal varices with blood
in the stomach and no other recognizable cause of bleeding.
92 (86.7%) patients had variceal bleeding among 106 patients who
were admitted to the ICU due to gastrointestinal bleeding. Variceal-
bleeding patients were much more than nonvariceal-bleeding
patients in the three different age groups. Younger patients with
variceal bleeding (< 65 years old) were predominantly more than
the elderly patients (> 65 years old) in the subgroup analysis of
variceal-bleeding patients.
Table 3 shows the association between the different age groups
and the clinical outcomes. Compared with patients aged < 65 years,
those aged 65e74 years showed no signiﬁcant correlation with
mortality and clinical outcomes (regardless of compensated or
decompensated cirrhosis). In patients with compensated cirrhosis,
age  75 years did not have any signiﬁcant correlation with mor-
tality or outcomes. However, in patients with decompensated
cirrhosis, age  75 years was signiﬁcantly correlated with in-
hospital mortality, 6-month mortality, hospital days, and
hospital-free days (compared with patients aged < 65 years).
Similar results were seen in the KaplaneMeier survival curves. In
this analysis, comparedwith patients aged < 65 years, those aged
75 years with decompensated cirrhosis had signiﬁcant differences
in the in-hospital and 6-month mortality (Figure 1). After adjusting
for sex, coronary artery disease, etiology of ICU admission, APACHE
II score, Model for End-Stage Liver Disease score, and mechanical
ventilation, the signiﬁcant correlation with in-hospital and 6-
Table 1
Demographic data, clinical, and laboratory characteristics of 226 critically ill patients with cirrhosis.a
Parameter All patients (n ¼ 226) Age < 65 y (n ¼ 153) Age 65e74 y (n ¼ 40) Age  75 y (n ¼ 33) p
Decompensated cirrhosis 159 (70.4) 115 (75.2) 23 (57.5) 21 (63.6) 0.061
Age (y) 57.7 ± 0.9 49.6 ± 0.7 69.8 ± 0.5 80.7 ± 0.7 < 0.001
Male:female 166:60 126:27 25:15 15:18 < 0.001
Coronary artery disease 39 (17.3) 14 (9.2) 10 (25.0) 15 (45.5) < 0.001
Body mass index (kg/m2) 23.9 ± 0.3 24.0 ± 0.3 23.2 ± 0.4 24.4 ± 1.0 0.484
Mean arterial pressure (mmHg) 79.5 ± 1.1 78.3 ± 1.4 82.2 ± 2.2 81.6 ± 3.1 0.323
APACHE II score 18.7 ± 0.5 17.6 ± 0.7 20.1 ± 1.2 21.8 ± 1.4 0.010
ChildePugh score 9.4 ± 0.1 9.8 ± 0.2 8.4 ± 0.3 9.1 ± 0.3 0.001
MELD score 20.9 ± 0.5 21.6 ± 0.7 19.8 ± 1.0 19.0 ± 1.4 0.170
Etiology of ICU admission 0.111
Septic shock 71 (31.4) 44 (28.8) 17 (42.5) 10 (30.3)
Gastrointestinal bleeding 106 (46.9) 78 (51.0) 13 (32.5) 15 (45.5)
Variceal bleeding b 92 a 67 12 13
Nonvariceal bleeding 14 11 1 2
Isolated respiratory failure 14 (6.2) 11 (7.2) 0 (0.0) 3 (9.1)
Others 35 (15.5) 20 (13.1) 10 (25) 5 (15.2)
Etiology of liver cirrhosis < 0.001
Viral hepatitis 89 (39.4) 41 (26.8) 27 (67.4) 21 (63.6)
Alcoholic 84 (37.2) 76 (49.7) 5 (12.5) 3 (9.1)
Alcohol with viral hepatitis 29 (12.8) 28 (18.3) 1 (2.5) 0 (0.0)
Cryptogenic 24 (10.6) 8 (5.2) 7 (17.5) 9 (27.3)
Hepatic encephalopathy 102 (45.1) 73 (47.7) 17 (42.5) 12 (36.4) 0.461
Ascites 142 (62.8) 97 (63.4) 22 (55.0) 23 (69.7) 0.419
Hepatoma 60 (26.5) 31 (20.3) 18 (45.0) 11 (33.3) 0.004
BUN (8e12 mg/dL) 39.2 ± 2.2 34.1 ± 2.5 47.8 ± 5.6 31.8 ± 5.5 0.002
Creatinine (0.4e1.2 mg/dL) 2.3 ± 0.2 2.1 ± 0.2 3.1 ± 0.5 2.3 ± 0.3 0.053
Sodium (136e144 mEq/L) 135.2 ± 0.4 135.2 ± 0.5 133.9 ± 0.9 136.7 ± 1.4 0.167
Potassium (3.5e5.1 mEq/L) 4.2 ± 0.1 4.1 ± 0.1 4.5 ± 0.2 4.6 ± 0.2 0.012
Albumin (3.5e5 g/dL) 2.6 ± 0.0 2.6 ± 0.0 2.8 ± 0.1 2.6 ± 0.1 0.136
Total bilirubin (0.3e1.2 mg/dL) 5.2 ± 0.4 6.3 ± 0.6 3.1 ± 0.7 2.7 ± 0.5 0.001
INR 1.6 ± 0.0 1.7 ± 0.0 1.4 ± 0.1 1.5 ± 0.1 0.016
Data are presented as n (%) or mean ± standard error of the mean.
APACHE II¼ Acute Physiology and Chronic Health Evaluation II; BUN¼ blood urea nitrogen; ICU¼ intensive care unit; INR¼ international normalized ratio; MELD¼Model for
End-Stage Liver Disease.
a Statistical comparison was performed with analysis of variance or Chi-square test.
b Among 92 patients admitted to the intensive care unit due to variceal bleeding, 86 patients were esophageal variceal bleeding and six patients were gastric variceal
bleeding.
Table 2
Intensive-care-unit related therapy, complications, mortality, and clinical outcomes analysis in 226 critically ill patients with cirrhosis.a
Parameter Age < 65 y (n ¼ 153) Age 65e74 y (n ¼ 40) Age  75 y (n ¼ 33) p
Mechanical ventilator 77 (50.3) 19 (47.5) 33 (51.5) 0.934
Renal replacement therapy 9 (5.9) 6 (15.0) 2 (6.1) 0.142
Complications
Hepatic encephalopathy 96 (62.7) 19 (47.5) 14 (42.4) 0.041
Gastrointestinal bleeding 116 (75.8) 18 (45.0) 19 (57.6) < 0.001
Sepsis 53 (34.6) 16 (40.0) 11 (33.3) 0.790
Acute kidney injury 43 (32.6) 10 (27.0) 12 (38.7) 0.591
ICU mortality 45 (29.4) 8 (20.0) 10 (30.3) 0.470
In-hospital mortality 62 (40.5) 15 (37.5) 23 (69.7) 0.006
Six-month mortality 71 (46.4) 20 (50.0) 24 (72.7) 0.023
Etiology of mortality 0.047
Sepsis 43 (28.1) 12 (30.0) 13 (39.4)
Gastrointestinal bleeding 11 (7.2) 0 2 (6.1)
Variceal bleeding 9 (5.9) 0 (0.0) 2 (6.1)
Nonvariceal bleeding 2 (1.3) 0 (0.0) 0 (0.0)
Acute kidney injury 6 (3.9) 2 (5.0) 5 (15.2)
Respiratory failure 10 (6.5) 5 (12.5) 4 (12.1)
Cardiac event 1 (0.7) 1 (2.5) 0 (0.0)
Ventilator-free days 9.1 ± 1.3 9.4 ± 2.4 4.8 ± 2.0 0.333
ICU days 5.3 ± 0.5 6.2 ± 1.1 8.2 ± 1.8 0.078
ICU-free days 17.8 ± 1.0 20.0 ± 1.7 16.8 ± 2.1 0.485
Hospital days 15.2 ± 1.2 17.2 ± 1.8 20.7 ± 3.1 0.147
Hospital-free days 25.7 ± 1.9 26.8 ± 3.5 14.2 ± 3.9 0.026
Data are presented as n (%) or mean ± standard error of the mean.
ICU ¼ intensive care unit.
a Statistical comparison was performed with analysis of variance or Chi-square test.
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Table 3
Association between age and clinical outcomes in critically ill patients with cirrhosis.a
Compensated cirrhosis (n ¼ 67) Decompensated cirrhosis (n ¼ 159)
Age 65e74 y (reference group: age < 65 y)
Cox regression analysis Hazard ratio 95% CI p Hazard ratio 95% CI p
ICU mortality 0.53 0.15e1.86 0.319 0.68 0.27e1.74 0.420
In-hospital mortality 0.63 0.23e1.71 0.359 1.02 0.51e2.02 0.954
Six-month mortality 0.70 0.28e1.78 0.453 1.26 0.70e2.27 0.444
Linear-regression analysis Unadjusted B (b) 95% CI p Unadjusted B (b) 95% CI p
Ventilator-free days 5.05 (0.21) 3.59e13.69 0.243 4.47 (0.13) 12.38e3.44 0.264
ICU days 1.65 (0.13) 1.67e4.98 0.325 0.31 (0.02) 2.93e3.55 0.849
ICU-free days 1.51 (0.06) 5.40e8.42 0.663 2.85 (0.08) 2.60e8.30 0.303
Hospital days 0.29 (0.01) 7.19e7.76 0.940 3.10 (0.07) 3.87e10.06 0.381
Hospital-free days 8.05 (0.14) 22.83e6.73 0.281 2.81 (0.04) 13.25e7.64 0.596
Age  75 y (reference group: age < 65 y)
Cox regression analysis Hazard ratio 95% CI p Hazard ratio 95% CI p
ICU mortality 1.09 0.35e3.39 0.878 0.91 0.38e2.18 0.835
In-hospital mortality 1.70 0.73e3.98 0.219 1.81 1.01e3.25 0.046
Six-month mortality 1.64 0.71e3.82 0.247 1.82 1.04e3.20 0.036
Linear-regression analysis Unadjusted B (b) 95% CI p Unadjusted B (b) 95% CI p
Ventilator-free days 3.55 (0.11) 14.71e7.61 0.522 4.50 (0.15) 11.50e2.51 0.205
ICU days 3.04 (0.21) 0.73e6.82 0.112 2.85 (0.14) 0.51e6.22 0.096
ICU-free days 3.87 (0.13) 11.71e3.97 0.328 0.78e0.02 4.88e6.45 0.785
Hospital days 1.33 (0.04) 7.16e9.82 0.755 7.74 (0.17) 0.51e14.97 0.036
Hospital-free days 8.05 (0.14) 22.83e6.73 0.281 12.79 (0.19) 23.64e1.94 0.021
CI ¼ conﬁdence interval; ICU ¼ intensive care unit.
a Statistical analysis was performed with univariate Cox proportional-hazard and linear-regression analysis.
C.-Y. Chen et al.236month mortality was maintained in patients aged  75 years who
had decompensated cirrhosis (Table 4).
4. Discussion
The present retrospective study was designed to evaluate the
inﬂuence of different age groups on critically ill patients with
cirrhosis. One strength of the present studywas the homogeneity of
study participants. Differences were observed when the patients
were classiﬁed according to the severity of cirrhosis. In patients
with compensated cirrhosis, old age did not affect short- or
medium-term outcomes. In those with decompensated cirrhosis,
age  75 years was an independent risk factor for mortality after
ICU discharge.
In general, critically ill elderly patients showed a higher crude
ICU mortality than younger patients. However, the differences
almost disappear after mortality is adjusted for the severity of the
disease, matched by comorbidity, and adjusted for treatment16.
Several reports have identiﬁed that severity of illness is the most
important independent factor affecting short-term mortality5,9,10.
In addition to the severity of illness, several risk factors have been
identiﬁed as associated with ICU mortality in elderly patients,
including the APACHE score, Simpliﬁed Acute Physiology Score, and
the number of organ failures17e19. Very advanced age (> 80 years) is
a minor risk factor for ICU mortality20. It is similar in cirrhotic pa-
tients during an ICU stay. In these patients, the number of organ-
system failures is an even more signiﬁcant risk factor for mortal-
ity than the severity of cirrhosis itself8. For instance, acute kidney
injury is a common and ominous event in patients with cirrhosis21,
and renal replacement therapy seems to be futile in these patients
with mechanical ventilation22. Furthermore, when there are more
than three nonhematologic organ failures after 3 days spent in the
ICU, the mortality rate is as high as 90%8. In these studies, age alone
is seldom a risk factor for ICU outcomes. Our results are in line with
those of previous reports, and support the opinion that treatment
should not be withheld/withdrawn in elderly patients with
cirrhosis when ICU admission is indicated, as there is no difference
in ICU outcomes between the different age groups, regardless of
compensated or decompensated cirrhosis.After ICU discharge, in-hospital mortality is consistently higher
in the elderly than in younger patients2. As to later mortality (6
months and 1 year or more after ICU), age has been conﬁrmed as an
important factor10,23,24. Other factors associated with later mor-
tality include APACHE score, presence of an underlying fatal dis-
ease, severe functional limitation, and quality of life (QOL) before or
immediately following ICU stay20,24,25. The inﬂuence of age on post-
ICU outcomes showed some difference in cirrhotic patients. Before
dividing patients according to the severity of cirrhosis, there were
signiﬁcant differences in the in-hospital and 6-month mortality of
the different age groups (Table 2); however, old age was not a
signiﬁcant predictor for mortality after patients with decom-
pensated cirrhosis were excluded (Table 3). This suggests that the
severity of cirrhosis has more inﬂuence than age itself on the
mortality after ICU discharge.
In contrast to that in patients with compensated cirrhosis, our
results showed that age  75 years was an independent prognostic
factor for post-ICU mortality in patients with decompensated
cirrhosis. There might be two explanations for this. First, previous
studies have suggested that age is an independent risk factor for
later mortality of critically ill patients10,23,24, which is also true for
patients with decompensated cirrhosis. Second, treatment for these
patients may be withheld or withdrawn more often. Hamel et al16
reported that, consistent with anticipated poor outcomes, life-
sustaining treatments are much more often withheld/withdrawn
in elderly critically ill patients. Boumendil et al25 showed that pa-
tients in the ICU aged > 80 years receive less treatment when
compared with younger patients. Fuchs et al26 also reported that,
with aging, patients receive less treatment, including renal
replacement therapy, vasopressors, and mechanical ventilation.
Therefore, although the percentage of renal replacement therapy
and mechanical ventilation in the different age groups during the
ICU stays was not signiﬁcantly different (Table 2), these life-
sustaining therapies might be withheld/withdrawn after
discharge from the ICU because of anticipated poorer outcomes in
patients with concomitant old age and severe fatal organ disease
(decompensated cirrhosis). Such decisions may also heavily inﬂu-
ence the results of post-ICU mortality seen in the present study. In
fact, decisions to withhold/withdraw treatments often reﬂect
Figure 1. Survival curve of intensive-care-unit, in-hospital, and 6-month mortality for critically ill patients with compensated or decompensated cirrhosis that were divided into the
< 65-year, 65e74-year, and  75-year age groups (reference group: age < 65 years). ICU ¼ intensive care unit.
Table 4
Prognostic value of parameters for in-hospital and 6-month mortality in 159 critically ill patients with decompensated cirrhosis (n ¼ 159).a
Parameter In-hospital mortality 6 mo mortality
Hazard ratio 95% CI p Hazard ratio 95% CI p
Sex (reference group: female) 0.81 0.45e1.47 0.493 1.01 0.60e1.72 0.962
Coronary artery disease 0.64 0.29e1.40 0.259 0.71 0.35e1.44 0.338
Etiology of ICU admission, (reference group: other)
Septic shock 0.79 0.35e1.77 0.559 0.84 0.39e1.81 0.840
Gastrointestinal bleeding 0.67 0.31e1.47 0.318 0.71 0.34e1.48 0.363
Isolated respiratory failure 0.43 0.09e2.09 0.293 0.62 0.16e2.42 0.487
Age (reference group: age < 65 y)
Age 65e74 y 1.22 0.58e2.58 0.609 1.52 0.79e2.92 0.211
Age  75 y 2.61 1.27e5.39 0.009 2.34 1.16e4.70 0.017
APACHE II score 1.07 1.02e1.11 0.004 1.05 1.01e1.10 0.010
MELD score 1.07 1.04e1.11 < 0.001 1.07 1.04e1.11 < 0.001
Mechanical ventilator 2.51 1.34e4.70 0.004 2.34 1.34e4.09 0.003
APACHE II ¼ Acute Physiology and Chronic Health Evaluation II; CI ¼ conﬁdence interval; ICU ¼ intensive care unit; MELD ¼ Model for End-Stage Liver Disease.
a Statistical analysis was performed with multivariate Cox proportional hazard.
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reported incorrect in > 50% of cases27.
Initially, the patients were willing to consent to ICU care, given
the reasonable chance of a good outcome in terms of either survival
or QOL28. Thus, both functional status and QOL before or just after
ICU stay are important prognostic factors for elderly patients in the
ICU. Home return is another important outcome for elderly pa-
tients, because it can be considered as a surrogate measure of a
good functional status20. These prognostic factors, and their asso-
ciations for elderly patients, were not included for analysis in the
present study. Thus, a prospective cohort study is necessary to test
and verify our conclusions.
In Table 4, there is no signiﬁcant difference in the hazard ratio of
etiology of ICU admission. Current prognostic scores and other
clinical or biological factors could not determine, on an individual
basis, whether ICU admission in a critically ill cirrhotic patient is
futile or not12,29. General ICU scores are more accurate at grading
multiple organ failure for patients with cirrhosis (Table 4). How-
ever, a difﬁculty comes from the fact that, even when critically ill
cirrhotic patients develop multiple organ failure, the liver is central
in the outcome.
In summary, old age alone is not associated with adverse effects
on ICU mortality, VFDs, ICU days, or ICU-free days of cirrhotic pa-
tients (regardless of compensated or decompensated cirrhosis)
during their stay in the ICU. A similar result was found in a recent
study of ICU patients with severe sepsis30. After ICU discharge, age
 75 years is an independent prognostic factor for hospital days, in-
hospital mortality, and 6-month mortality for patients with
decompensated cirrhosis. Our results support that age should not
be a criterion for ICU admission and use of ICU resources. However,
it should be used cautiously in interpreting the adverse effects of
old age on post-ICU outcomes, as these results may relate to
common life-sustaining therapies that may be withheld/with-
drawn in patients with concomitant old age and fatal organ disease.
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